Your Article Summary
See Latest ArticlesEvaluation of Prokinetic Action of Clarithromycin using Orocecal Transit Time in Healthy Human Subjects
The Internet Journal of Gastroenterology, 06/30/09
Shobha JC et al. - The prokinetic action of clarithromycin is substantiated in this study as it significantly reduced OTT as compared to placebo and loperamide. Sulfapyridine lag time in saliva and hence OTT were significantly reduced by clarithromycin indicating its prokinetic effect like erythromycin. However, the clinical utility of this decrease in the lag time has to be evaluated in further studies before any therapeutic indication can be recommended.
Related Articles
Borderline CD30+ cutaneous lymphoproliferative disorder: report of a case with expression of cytotoxic markers and response to clarithromycin
Journal of Cutaneous Pathology, 11/30/09
Relevance Score: 87%
Physiologically-Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Drug Metabolism and Disposition, 11/20/09
Relevance Score: 87%
Clarithromycin Resistance and Efficacy of Clarithromycin-Containing Triple Eradication Therapy for Helicobacter pylori Infection in Type 2 Diabetes Mellitus Patients
Southern Medical Journal, 11/09/09
Relevance Score: 87%
Clarithromycin–Amoxycillin-Containing Triple Therapy: A Valid Empirical First-Line Treatment for Helicobacter pylori Eradication in Hong Kong
Helicobacter, 11/09/09
Relevance Score: 87%
Physiologically-Based Pharmacokinetic Model of Mechanism-Based Inhibition of CYP3A by Clarithromycin
Drug Metabolism and Disposition, 11/06/09
Relevance Score: 87%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance
Journal of Clinical Oncology, 12/18/09
New modalities and paradigms for sedation: new sedation agents
Techniques in Gastrointestinal Endoscopy , 12/18/09
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
Digestive and Liver Diseases, 12/18/09